Treatment of relapsed and refractory multiple myeloma
The approach to the patient with relapsed or relapsed/refractory multiple myeloma (RRMM) requires a careful evaluation of the results of previous treatments, the toxicities associated with them and an assessment of prognostic factors. Since the majority of patients will have received prior therapy w...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2016-04-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/7675 |